Clinical supply chain management plays an integral role in ensuring the seamless delivery of investigational product (IP) to clinical trial sites. This white paper covers some key components, offers insights and best practices for supply chain managers. It emphasizes strategies to mitigate risks, optimize resources, and maintain regulatory compliance while supporting the timely execution of clinical studies.
Related Resources
All Resources
post
Oral Drug Product Development of Small Molecules
Read More
white-paper
The New Chemistry, Manufacturing, and Controls (CMC) Regulations in China
Read More
post
Why FDA PreCheck is a game-changer for small & mid-sized pharma — and how these companies should lean in
Read More
white-paper
Solid-Phase Oligonucleotide Synthesis (SPOS) and Liquid-Phase Oligonucleotide Synthesis (LPOS): Complementary or Competitive Processes?
Read More
Let's move from science to success.
Let’s Talk